...
首页> 外文期刊>Steroids: An International Journal >Syntheses of 19-(O-(carboxymethyl)oxime) haptens of epipregnanolone and pregnanolone.
【24h】

Syntheses of 19-(O-(carboxymethyl)oxime) haptens of epipregnanolone and pregnanolone.

机译:表孕烯醇酮和孕烯醇酮的19-(O-(羧甲基)肟)半抗原的合成。

获取原文
获取原文并翻译 | 示例

摘要

O-(Carboxymethyl)oximes 1 and 2 derived from two epimeric 5beta-pregnanolones (3beta-hydroxy-5beta-pregnan-20-one and 3alpha-hydroxy-5beta-pregnan-20-one) in position 19 were prepared. Two synthetic routes were employed, both using protection of the 20-keto group after reduction into the (20R)-alcohol in the form of acetate. In the first route, (20R)-19-hydroxy-5beta-pregnan-3beta,20-diyl diacetate (3) was transformed into the corresponding 19-[O-(carboxymethyl)oxime] methyl ester 6, then deacetylated by acid and partially silylated with tert-butyldimethylsilyl chloride. The desired 3-O-silylated derivative 8 was separated, oxidized to the 20-ketone and protecting groups were sequentially removed to give the first title hapten 1. The second route started from (20R)-19-hydroxy-3-oxopregn-4-en-20-yl acetate (11), which was hydrogenated in the presence of base to the 5beta-pregnan-3-one derivative 12, protected in position 19 with tert-butyldimethylsilyl group and reduced with borohydride. The prevailing 3alpha-alcohol 15 was separated, protected in position 3 with a methoxymethyl group, deprotected in position 19 and transformed into the 19-[O-(carboxymethyl)oxime] 19. After deacetylation, esterification with diazomethane and oxidation in position 20, the pregnanolone skeleton was regenerated. Final deprotection steps gave the second title hapten 2. Both haptens, i.e., (19E)-3beta- and -3alpha-hydroxy-20-oxo-5beta-pregnan-19-al 19-[O-(carboxymethyl)oxime], were designed for the development of immunoassays of the corresponding parent neuroactive steroids.
机译:制备了在位置19上衍生自两种表观异构5β-孕烯醇酮(3β-羟基-5β-pregnan-20-one和3α-羟基-5β-pregnan-20-one)的O-(羧甲基)肟1和2。采用了两种合成途径,两种途径均是在还原为乙酸盐形式的(20R)-醇后使用20-酮基的保护。在第一种方法中,将(20R)-19-羟基-5beta-pregnan-3beta,20-二乙酸二丁酯(3)转化为相应的19- [O-(羧甲基)肟]甲酯6,然后用酸将其脱乙酰基,用叔丁基二甲基甲硅烷基氯部分甲硅烷基化。分离出所需的3-O-甲硅烷基化衍生物8,氧化成20-酮,并依次除去保护基团,得到第一标题半抗原1。第二条路线从(20R)-19-羟基-3-氧杂戊烯-4开始在碱的存在下将-en-20-乙酸乙烯酯(11)氢化成5β-pregnan-3-one衍生物12,在19位用叔丁基二甲基甲硅烷基保护并用硼氢化物还原。分离出占优势的3α-醇15,在3位用甲氧基甲基保护,在19位脱保护并转化为19- [O-(羧甲基)肟]19。脱乙酰基后,用重氮甲烷酯化并在20位氧化,孕烷酮骨架得以再生。最终的脱保护步骤得到了第二个半抗原2。两个半抗原,即(19E)-3beta-和-3alpha-hydroxy-20-oxo-5beta-pregnan-19-al 19- [O-(羧甲基)肟]均为为开发相应亲本神经活性类固醇的免疫分析方法而设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号